Clinical Trials
42 trialsDose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
Nuvation Bio Inc.
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors
University of Southern California
Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors
National Institutes of Health Clinical Center (CC)
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Elevation Oncology
A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors
Valerio Therapeutics
Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors
Tango Therapeutics, Inc.
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Pfizer
ORCHID-1
Medikine, Inc.
Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.
Haihe Biopharma Co., Ltd.
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
OHSU Knight Cancer Institute
A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors
Leap Therapeutics, Inc.
ICE
Centre Hospitalier Universitaire de Besancon
LODESTAR
pharmaand GmbH
A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors
Genmab
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
Nuvation Bio Inc.
Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer
Eastern Cooperative Oncology Group
Methionine-Restricted Diet to Potentiate The Effects of Radiation Therapy
West Virginia University
Hypertension Management in Cancer Patients
Duke University
A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer
National Institutes of Health Clinical Center (CC)
Safety Study of MGD009 in B7-H3-expressing Tumors
MacroGenics
NeoFIND
Advanced Accelerator Applications
Cannabis Oil and Radiation Therapy for the Management of Pain
Tetra Bio-Pharma
ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain
InSightec
Quell Opioid Reduction and Pain Relief in Patients With Cancer
Scripps Translational Science Institute
Effect of Cancer Nurse Navigators on Patient Outcomes
University of Wisconsin, Madison
Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis
M.D. Anderson Cancer Center
N1
CureOne
111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer
National Institutes of Health Clinical Center (CC)
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Measuring the Effect of Radiation Therapy on Patient Activity Levels
University of Pittsburgh
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
Cota Inc.
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
University Health Network, Toronto
Group-based or Individual Information About Disease and Treatment Plan
Norwegian University of Science and Technology
A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer
Otsuka Novel Products GmbH
Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases
Virginia Commonwealth University
A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)
Merck Sharp & Dohme LLC
Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors
Mirati Therapeutics Inc.
Figitumumab Combined With Pegvisomant For Advanced Solid Tumors
Pfizer
Safety Study of CALAA-01 to Treat Solid Tumor Cancers
Calando Pharmaceuticals
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
Emory University